Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of hereditary dystrophic epidermolysis bullosa with Polyphenon E
2009-012750-21Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Nov 2009
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of green tea extract in dystrophic epidermolysis bullosa (DEB) and epidermolysis bullosa (EB), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Responder rate with ≥20% reduction in number of cutaneous bullae. Started Nov 2009; status: active.
02
Drugs
green tea extract
03
Conditions
dystrophic epidermolysis bullosa (DEB)epidermolysis bullosa (EB)
Beyond the preview
Go deeper on 2009-012750-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012750-21.